Finish Line (FINL) PT Lowered to $14 at Canaccord Genuity Following Weak 4Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Finish Line (FINL) PT Lowered to $14 at Credit Suisse
March 27, 2017 8:44 AM EDTCredit Suisse lowered its price target on Finish Line (NASDAQ: FINL) to $14.00 (from $19.00) while maintaining a Neutral rating.
... MoreFinish Line (FINL) PT Lowered to $15 at Wedbush Following 4Q
March 27, 2017 7:26 AM EDTWedbush lowered its price target on Finish Line (NASDAQ: FINL) to $15.00 (from $18.00) while maintaining a Neutral rating. FINL reported EPS of $0.50, $0.20 below the street due to significant merchandise margin pressure in order to right size inventory.
Analyst Christopher Svezia commented, "We... More
Put options list with increasing unusual volume
March 27, 2017 5:13 AM EDTPut options list with increasing unusual volume: ILG FINL GIII THC HUN CRC CBL BBG GWW CNC GME
... MorePre-Open Movers 03/24: (HTGM) (SEAS) (MU) Higher; (XENE) (FINL) (GME) Lower (more...)
March 24, 2017 9:31 AM EDTToday's Pre-Open Movers
HTG Molecular Diagnostics (NASDAQ: HTGM) 73.8% HIGHER; adds to Thursday's big gains following results.
Xenon Pharmaceuticals Inc. (Nasdaq: XENE) 49.2% LOWER; reported topline efficacy results from the... More
Finish Line (FINL) Falls 14% Pre-Market Following Q4 EPS Miss and Guidance
March 24, 2017 9:25 AM EDTFinish Line (NASDAQ: FINL) shares down 14% pre-market as the company reported fourth quarter EPS below consensus.
Finish Line (FINL) Misses Q4 EPS by 21c, Comps Decline 4.5%
March 24, 2017 7:13 AM EDT(Updated - March 24, 2017 7:15 AM EDT with guidance)
Finish Line (NASDAQ: FINL) reported Q4 EPS of $0.50, $0.21 worse than the analyst estimate of $0.71. Revenue for the quarter came in at $557.5 million versus the consensus estimate of $550.46 million.
Finish Line comparable sales decreased... More
Call option list with increasing unusual volume
March 24, 2017 5:31 AM EDTCall option list with increasing unusual volume: HRG PTC SWC WWAV SFM CSC XLRE FINL
... MoreFinish Line (FINL) April volatility elevated at 55 into Q4
March 23, 2017 8:51 AM EDTFinish Line (NASDAQ: FINL) April call option implied volatility is at 55, May is at 47; compared to its 52-week range of 31 to 60 into the expected release of Q4 results on March 24.
... More